Cargando…
Gene Expression Changes by Diallyl Trisulfide Administration in Chemically-induced Mammary Tumors in Rats
Diallyl trisulfide (DATS) was shown to be a potent inhibitor of luminal-type MCF-7 xenograft growth in vivo. The present study was conducted to determine the preventive effect of DATS administration using an N-methyl-N-nitrosourea (MNU)-induced rat mammary tumor model, which shares molecular resembl...
Autores principales: | Hahm, Eun-Ryeong, Singh, Shivendra V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984650/ https://www.ncbi.nlm.nih.gov/pubmed/35419300 http://dx.doi.org/10.15430/JCP.2022.27.1.22 |
Ejemplares similares
-
Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide
por: Hahm, Eun-Ryeong, et al.
Publicado: (2022) -
Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats
por: Kim, Su-Hyeong, et al.
Publicado: (2020) -
Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis
por: Hahm, Eun-Ryeong, et al.
Publicado: (2021) -
Exploring the role and mechanisms of diallyl trisulfide and diallyl disulfide in chronic constriction-induced neuropathic pain in rats
por: Wang, Gang, et al.
Publicado: (2020) -
Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment
por: Puccinelli, Michael T., et al.
Publicado: (2017)